/Companies

Completeomics

Founded 2019 · 14 employees on LinkedIn · 1 known investors

Find your way into Completeomics

Sign up to see every warm intro you have to Completeomics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Completeomics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Complete Omics develops a clinical proteomics platform that identifies patient-specific neoantigens to enable personalized cancer therapeutics. The platform guides the design of targeted treatments such as mRNA vaccines and cell therapies.

Founders & leadership

Completeomics was founded in 2019 by Ming Zhang.

MZ
Ming ZhangCo-Founder and Chief Intellectual Property Officer

Investors · 1

Frequently asked questions

What does Completeomics do?
Complete Omics develops a clinical proteomics platform that identifies patient-specific neoantigens to enable personalized cancer therapeutics. The platform guides the design of targeted treatments such as mRNA vaccines and cell therapies.
Who founded Completeomics?
Completeomics was founded by Ming Zhang in 2019.
Who are Completeomics's investors?
Completeomics's investors include Qiming Venture Partners.